Zobrazeno 1 - 10
of 1 310
pro vyhledávání: '"E, Jonsson"'
Autor:
Sara E. Stinson, Anna E. Jonsson, Mette K. Andersen, Morten A. V. Lund, Louise Aas Holm, Cilius E. Fonvig, Yun Huang, Evelina Stankevič, Helene Bæk Juel, Lars Ängquist, Thorkild I. A. Sørensen, Emily L. Ongstad, Ranjitha Gaddipati, Joseph Grimsby, Christopher J. Rhodes, Oluf Pedersen, Michael Christiansen, Jens‐Christian Holm, Torben Hansen
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 3 (2023)
Background Lectin‐like oxidized low‐density lipoprotein (ox‐LDL) receptor‐1 is a scavenger receptor for oxidized low‐density lipoprotein. In adults, higher soluble lectin‐like ox‐LDL receptor‐1 (sLOX‐1) levels are associated with ca
Externí odkaz:
https://doaj.org/article/f8e2b7bde0c84cd1a9abf38ec9a67ea9
Autor:
F. Cámara, D. Holtstam, N. Jansson, E. Jonsson, A. Karlsson, J. Langhof, J. Majka, A. Zetterqvist
Publikováno v:
European Journal of Mineralogy, Vol 33, Pp 659-673 (2021)
Zinkgruvanite, ideally Ba4Mn42+Fe23+(Si2O7)2(SO4)2O2(OH)2, is a new member of the ericssonite group, found in Ba-rich drill core samples from a sphalerite- and galena- and diopside-rich metatuffite succession from the Zinkgruvan mine, Örebro County,
Externí odkaz:
https://doaj.org/article/101c341065a9441180cc4298a18ca055
Autor:
Asmat Ullah, Evelina Stankevic, Louise Aas Holm, Sara E. Stinson, Helene Bæk Juel, Cilius E. Fonvig, Morten A. V. Lund, Cæcilie Trier, Line Engelbrechtsen, Lars Ängquist, Anna E. Jonsson, Oluf Pedersen, Niels Grarup, Jens-Christian Holm, Torben Hansen
Publikováno v:
Antioxidants, Vol 12, Iss 8, p 1613 (2023)
Bilirubin is the end product of heme catabolism, mainly produced by the breakdown of mature red blood cells. Due to its anti-inflammatory, antioxidant, antidiabetic, and antilipemic properties, circulating bilirubin concentrations are inversely assoc
Externí odkaz:
https://doaj.org/article/14dc5f2f8d7241fe8e55ead60f1bab22
Autor:
David S Mathiesen, Jonatan I Bagger, Katrine B Hansen, Anders E Junker, Astrid Plamboeck, Signe Harring, Thomas Idorn, Mads Hornum, Jens J Holst, Anna E Jonsson, Torben Hansen, Tina Vilsbøll, Asger Lund, Filip K Knop
Publikováno v:
Endocrine Connections, Vol 9, Iss 12, Pp 1221-1232 (2020)
The T allele of TCF7L2 rs7903146 is a common genetic variant associated with type 2 diabetes (T2D), possibly by modulation of incretin action. In this study, we evaluated the effect of the TCF7L2 rs7903146 T allele on the incretin effect and other gl
Externí odkaz:
https://doaj.org/article/cc04fbb5850746b1808b208996a16e7d
Autor:
Julie R. Lundgren, Kristine Færch, Daniel R. Witte, Anna E. Jonsson, Oluf Pedersen, Torben Hansen, Torsten Lauritzen, Jens J. Holst, Dorte Vistisen, Marit E. Jørgensen, Signe S. Torekov, Nanna B. Johansen
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-9 (2019)
Abstract Background and aim Cardiovascular diseases (CVDs) are globally the leading cause of death and hypertension is a significant risk factor. Treatment with glucagon-like peptide-1 (GLP-1) receptor agonists has been associated with decreases in b
Externí odkaz:
https://doaj.org/article/2414a8a9200545269eced300e7a98d3d
Autor:
Mette K. Andersen, Lars Ängquist, Jette Bork-Jensen, Anna E. Jonsson, Sara E. Stinson, Camilla H. Sandholt, Malte Thodberg, Laura Maarit Pikkupeura, Emily L. Ongstad, Niels Grarup, Arne Astrup, Oluf Pedersen, Kristine Williams, Romain Barrès, Thorkild I.A. Sørensen, Allan Linneberg, Joseph Grimsby, Christopher J. Rhodes, Torben Hansen
Publikováno v:
Diabetes Care. 46:985-992
OBJECTIVE The association between FTO rs9939609 and obesity is modified by physical activity (PA) and/or insulin sensitivity (IS). We aimed to assess whether these modifications are independent, to assess whether PA and/or IS modify the association b
Autor:
Mahesh M Umapathysivam, Elisa Araldi, Benoit Hastoy, Adem Y Dawed, Hasan Vatandaslar, Shahana Sengupta, Adrian Kaufmann, Søren Thomsen, Bolette Hartmann, Anna E Jonsson, Hasan Kabakci, Swaraj Thaman, Niels Grarup, Christian T Have, Kristine Færch, Anette P Gjesing, Sameena Nawaz, Jane Cheeseman, Matthew J Neville, Oluf Pedersen, Mark Walker, Christopher Jennison, Andrew T Hattersley, Torben Hansen, Fredrik Karpe, Jens J Holst, Angus G Jones, Michael Ristow, Mark I McCarthy, Ewan R Pearson, Markus Stoffel, Anna L Gloyn
Patients with type 2 diabetes vary in their response to currently available therapeutic agents (including GLP-1 receptor agonists) leading to suboptimal glycemic control and increased risk of complications. We show that human carriers of hypomorphic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::157451176660a0e343840228d18dc298
https://doi.org/10.1101/2023.04.07.23288197
https://doi.org/10.1101/2023.04.07.23288197
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.